2022-07-05-世界卫生组织-Immunization_Cyprus_2022_country_profile_16页_343kb

WHO and UNICEF provide country-specific immunization coverage estimates for Cyprus based on reported data, surveys, and expert judgment, with annual data from 2010 to 2021.

Key vaccines covered include BCG, DTP1/DTP3, Pol3, IPV1, MCV1/MCV2, RCV1, HepBB/HepB3, Hib3, RotaC, and PcV3. Coverage rates are generally high, with most estimates close to 99% or higher for several vaccines, though variability exists.

Methodology: Estimates are derived from official national reports, population-based surveys (e.g., the 2015 Cyprus Childrens Immunization Survey frequently cited for calibration), and administrative data. Coverage recalculations use independent denominators from UN Population Prospects when available. Grades of confidence (GoC) indicate data support, ranging from ••• (very well-supported) to • (less supported), without classical uncertainty measures.

Caution: Data quality varies, and some estimates face challenges like vaccine stock-outs or insufficient data sources. For example, early years lack data, and extrapolation is used in some cases. Estimates should be evaluated carefully based on the target objective.

High coverage was recorded for BCG, DTP1/DTP3, and Pol3 in many years, with challenges noted primarily for HepBB and other newer vaccines where data is limited. Methodological changes for IPV1 began in 2015, and some vaccines like RCV1 are estimated based on measles data.